Next Article in Journal
Mind-Body Medicine in Pediatrics
Next Article in Special Issue
Pediatric Perioperative Pulmonary Arterial Hypertension: A Case-Based Primer
Previous Article in Journal
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
Previous Article in Special Issue
The Pulmonary Circulation in the Single Ventricle Patient

Diagnostic Approach to Pulmonary Hypertension in Premature Neonates

Division of Neonatology, Department of Pediatrics, The Women & Children’s Hospital of Buffalo, University at Buffalo, 219 Bryant Street, Buffalo, NY 14222-2006, USA
Children 2017, 4(9), 75;
Received: 12 June 2017 / Revised: 1 August 2017 / Accepted: 9 August 2017 / Published: 24 August 2017
(This article belongs to the Special Issue New Trend in Pediatric Cardiology: Pulmonary Hypertension)
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease in premature infants following respiratory distress at birth. With increasing survival of extremely low birth weight infants, alveolar simplification is the defining lung characteristic of infants with BPD, and along with pulmonary hypertension, increasingly contributes to both respiratory morbidity and mortality in these infants. Growth restricted infants, infants born to mothers with oligohydramnios or following prolonged preterm rupture of membranes are at particular risk for early onset pulmonary hypertension. Altered vascular and alveolar growth particularly in canalicular and early saccular stages of lung development following mechanical ventilation and oxygen therapy, results in developmental lung arrest leading to BPD with pulmonary hypertension (PH). Early recognition of PH in infants with risk factors is important for optimal management of these infants. Screening tools for early diagnosis of PH are evolving; however, echocardiography is the mainstay for non-invasive diagnosis of PH in infants. Cardiac computed tomography (CT) and magnetic resonance are being used as imaging modalities, however their role in improving outcomes in these patients is uncertain. Follow-up of infants at risk for PH will help not only in early diagnosis, but also in appropriate management of these infants. Aggressive management of lung disease, avoidance of hypoxemic episodes, and optimal nutrition determine the progression of PH, as epigenetic factors may have significant effects, particularly in growth-restricted infants. Infants with diagnosis of PH are managed with pulmonary vasodilators and those resistant to therapy need to be worked up for the presence of cardio-vascular anomalies. The management of infants and toddlers with PH, especially following premature birth is an emerging field. Nonetheless, combination therapies in a multi-disciplinary setting improves outcomes for these infants. View Full-Text
Keywords: pulmonary hypertension; bronchopulmonary dysplasia; premature newborns; nitric oxide; sildenafil pulmonary hypertension; bronchopulmonary dysplasia; premature newborns; nitric oxide; sildenafil
Show Figures

Figure 1

MDPI and ACS Style

Kumar, V.H.S. Diagnostic Approach to Pulmonary Hypertension in Premature Neonates. Children 2017, 4, 75.

AMA Style

Kumar VHS. Diagnostic Approach to Pulmonary Hypertension in Premature Neonates. Children. 2017; 4(9):75.

Chicago/Turabian Style

Kumar, Vasantha H.S. 2017. "Diagnostic Approach to Pulmonary Hypertension in Premature Neonates" Children 4, no. 9: 75.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop